Medicare, Medicaid, and Dual Eligibility Webinar Series
Resource updated 09/14/2023
Resource updated 09/14/2023
Resource updated 10/05/2023
Overview of the policies, procedures, and protocols developed by an ADAP and Part C clinic to establish access to antiretrovirals, including long-acting cabotegravir/rilpivirine.
Resource (Conference Presentation) updated 09/14/2023
Listening Session on how Policy Clarification Notice 16-02 and how the HRSA HAB RWHAP service categories and allowable uses of funds can be refreshed to best reflect new and emerging needs, science, and service delivery models.
Resource (Conference Presentation) updated 09/14/2023
Resource updated 03/11/2024
Resource updated 09/19/2023
Resource updated 04/16/2024
Resource updated 09/19/2023
Using a multidisciplinary approach to harness the electronic patient portal for completion of RWHAP six-month recertification documents, we were able to create a more patient-centered method that complies with program requirements. We will discuss the challenges, opportunities, and results of using such technology in program recertification.
Resource (Conference Presentation) updated 09/14/2023
California’s AIDS Drug Assistance Program (ADAP) and Pre-Exposure Prophylaxis Assistance Program (PrEP-AP) provide access to life-saving medications and insurance assistance for eligible California residents living with or at risk of acquiring HIV. This presentation will explore the efficacy of various program policy changes implemented by California during the COVID-19 pandemic.
Resource (Conference Presentation) updated 09/14/2023
Resource updated 12/22/2023
Resource updated 10/10/2023
Resource updated 02/16/2024
Resource updated 12/22/2023
Resource updated 10/30/2023
Resource updated 11/02/2023
Resource updated 01/29/2024
Resource updated 05/29/2024
Guide to help ADAPs prepare for and manage emergencies in order to ensure continued access to HIV medications.
Resource updated 09/19/2023
Information on HRSA's Office of Pharmacy Affairs, which administers the 340b program, which provides drug discounts to certain federal grantees,
Resource updated 09/20/2023